id	sid	eid	entity	type
aji-132	102	1	begum	PERSON
aji-132	102	2	s.	PERSON
aji-132	102	3	farooqui	GPE
aji-132	102	4	afreen	GPE
aji-132	102	5	s., & avunoori	ORG
aji-132	102	6	2024	CARDINAL
aji-132	104	1	asian	NORP
aji-132	104	2	7(1	CARDINAL
aji-132	104	3	79	CARDINAL
aji-132	104	4	89	CARDINAL
aji-132	104	5	https://journalaji.com/index.php/aji/article/view/132 asian journal of immunology	ORG
aji-132	104	6	7	CARDINAL
aji-132	104	7	1	CARDINAL
aji-132	104	8	79-89	DATE
aji-132	104	9	2024	DATE
aji-132	104	10	article no.aji.115805	PERSON
aji-132	104	11	nikita gupta	PERSON
aji-132	104	12	sana begum a++	PERSON
aji-132	104	13	varda farooqui	ORG
aji-132	104	14	pranitha avunoori a++	PERSON
aji-132	104	15	st. pauls college	ORG
aji-132	104	16	hyderabad	GPE
aji-132	104	17	telangana-510.	GPE
aji-132	105	1	india	GPE
aji-132	108	1	https://doi.org/10.9734/aji/2024/v7i1132	PRODUCT
aji-132	109	1	13/02/2024	DATE
aji-132	109	2	16/04/2024	DATE
aji-132	113	1	article https://doi.org/10.9734/aji/2024/v7i1132 https://www.sdiarticle5.com/review-history/115805 gupta et al	LAW
aji-132	113	2	asian	NORP
aji-132	113	3	j. immunol	PERSON
aji-132	113	4	7	CARDINAL
aji-132	113	5	1	CARDINAL
aji-132	114	1	79-89	DATE
aji-132	114	2	2024	DATE
aji-132	114	3	no.aji.115805 80	PERSON
aji-132	120	1	1	CARDINAL
aji-132	120	2	1.1	CARDINAL
aji-132	122	1	1	CARDINAL
aji-132	124	1	nsaids	ORG
aji-132	125	1	2	CARDINAL
aji-132	126	1	1.2	CARDINAL
aji-132	126	2	monocyte	GPE
aji-132	127	1	3	CARDINAL
aji-132	129	1	4	CARDINAL
aji-132	131	1	5,6	CARDINAL
aji-132	132	1	nf-κb	ORG
aji-132	134	1	7	CARDINAL
aji-132	135	1	2	CARDINAL
aji-132	135	2	2.1	CARDINAL
aji-132	137	1	8	CARDINAL
aji-132	140	1	9	CARDINAL
aji-132	140	2	10,11	CARDINAL
aji-132	141	1	12	CARDINAL
aji-132	144	1	4,12-20	CARDINAL
aji-132	145	1	cox-2	ORG
aji-132	146	1	nsaids	ORG
aji-132	146	2	cox-1	ORG
aji-132	146	3	cox-2” gupta et al.	ORG
aji-132	146	4	asian	NORP
aji-132	146	5	j. immunol	PERSON
aji-132	147	1	7	CARDINAL
aji-132	147	2	1	CARDINAL
aji-132	148	1	79-89	DATE
aji-132	148	2	2024	DATE
aji-132	148	3	81	CARDINAL
aji-132	149	1	12	CARDINAL
aji-132	151	1	nf-κb	NORP
aji-132	153	1	16,17	CARDINAL
aji-132	155	1	monocyte	PERSON
aji-132	155	2	1	CARDINAL
aji-132	157	1	18	CARDINAL
aji-132	162	1	deiminase	ORG
aji-132	164	1	19	CARDINAL
aji-132	165	1	2.2	CARDINAL
aji-132	165	2	2.2.1	CARDINAL
aji-132	165	3	2003	DATE
aji-132	165	4	igu	ORG
aji-132	166	1	4	CARDINAL
aji-132	167	1	mrl	PERSON
aji-132	167	2	igu	ORG
aji-132	168	1	21	CARDINAL
aji-132	169	1	igu	GPE
aji-132	170	1	1	CARDINAL
aji-132	170	2	egr1	ORG
aji-132	171	1	22	CARDINAL
aji-132	173	1	1	CARDINAL
aji-132	174	1	firstly	ORDINAL
aji-132	175	1	act1	ORG
aji-132	175	2	traf5	GPE
aji-132	175	3	ikki	PERSON
aji-132	176	1	gupta et al	PERSON
aji-132	177	1	asian	NORP
aji-132	177	2	j. immunol	PERSON
aji-132	177	3	7	CARDINAL
aji-132	177	4	1	CARDINAL
aji-132	178	1	79-89	DATE
aji-132	178	2	2024	DATE
aji-132	178	3	no.aji.115805	PERSON
aji-132	178	4	82 2.2.2	CARDINAL
aji-132	182	1	igg	ORG
aji-132	183	1	4	CARDINAL
aji-132	185	1	anti-cd40	PRODUCT
aji-132	185	2	25	CARDINAL
aji-132	187	1	igg	ORG
aji-132	189	1	mrl	PERSON
aji-132	189	2	11	CARDINAL
aji-132	190	1	3,26	CARDINAL
aji-132	191	1	27	CARDINAL
aji-132	192	1	2.2.3	CARDINAL
aji-132	193	1	monocyte	PERSON
aji-132	193	2	ic50	ORG
aji-132	193	3	1 to 20	CARDINAL
aji-132	194	1	28	CARDINAL
aji-132	195	1	0.3 to 30	CARDINAL
aji-132	196	1	28,32,33	CARDINAL
aji-132	199	1	32	CARDINAL
aji-132	199	2	cd54	ORG
aji-132	199	3	cd58	ORG
aji-132	199	4	ifn-γ	ORG
aji-132	202	1	30	CARDINAL
aji-132	203	1	29	CARDINAL
aji-132	204	1	10 and 30 mg/kg	QUANTITY
aji-132	204	2	ifn-γ	ORG
aji-132	205	1	29	CARDINAL
aji-132	207	1	33	CARDINAL
aji-132	208	1	ifn-γ	ORG
aji-132	210	1	34	CARDINAL
aji-132	211	1	cia	ORG
aji-132	211	2	th17	PRODUCT
aji-132	212	1	35	CARDINAL
aji-132	214	1	asian	NORP
aji-132	214	2	j. immunol	PERSON
aji-132	214	3	7	CARDINAL
aji-132	214	4	1	CARDINAL
aji-132	215	1	79-89	DATE
aji-132	215	2	2024	DATE
aji-132	215	3	no.aji.115805 83	PERSON
aji-132	216	1	2.3	CARDINAL
aji-132	218	1	bmp)2	ORG
aji-132	221	1	36	CARDINAL
aji-132	222	1	dlx5	ORG
aji-132	223	1	37	CARDINAL
aji-132	224	1	mapk	ORG
aji-132	224	2	36	CARDINAL
aji-132	225	1	igu	ORG
aji-132	227	1	38	CARDINAL
aji-132	229	1	igu	ORG
aji-132	231	1	2	CARDINAL
aji-132	231	2	th1	ORG
aji-132	234	1	th17	PRODUCT
aji-132	235	1	th1	ORG
aji-132	235	2	th17	PRODUCT
aji-132	239	1	mmps	PERSON
aji-132	239	2	asian	NORP
aji-132	239	3	j. immunol	PERSON
aji-132	240	1	7	CARDINAL
aji-132	240	2	1	CARDINAL
aji-132	241	1	79-89	DATE
aji-132	241	2	2024	DATE
aji-132	241	3	no.aji.115805	PERSON
aji-132	241	4	84	CARDINAL
aji-132	242	1	37	CARDINAL
aji-132	243	1	two	CARDINAL
aji-132	244	1	39	CARDINAL
aji-132	247	1	igu	ORG
aji-132	247	2	il1β	ORG
aji-132	247	3	40	CARDINAL
aji-132	248	1	41	CARDINAL
aji-132	250	1	nfatc1	GPE
aji-132	251	1	42	CARDINAL
aji-132	252	1	gan et al.	PERSON
aji-132	254	1	43	CARDINAL
aji-132	255	1	igu	GPE
aji-132	256	1	mmps	PERSON
aji-132	257	1	38	CARDINAL
aji-132	259	1	du et al	PERSON
aji-132	259	2	igu	GPE
aji-132	259	3	il-1β	PERSON
aji-132	260	1	5 μg/ml	QUANTITY
aji-132	260	2	50 μg/ml	QUANTITY
aji-132	261	1	24 weeks	DATE
aji-132	261	2	igu	GPE
aji-132	261	3	25 mg	QUANTITY
aji-132	261	4	twice daily	DATE
aji-132	262	1	44	CARDINAL
aji-132	263	1	igu	GPE
aji-132	264	1	opg	ORG
aji-132	265	1	opg	ORG
aji-132	265	2	45	CARDINAL
aji-132	266	1	46	CARDINAL
aji-132	268	1	igu	ORG
aji-132	270	1	3	CARDINAL
aji-132	270	2	igu	CARDINAL
aji-132	272	1	3	CARDINAL
aji-132	272	2	igu	GPE
aji-132	273	1	dlx5	ORG
aji-132	274	1	igu	ORG
aji-132	276	1	asian	NORP
aji-132	276	2	j. immunol	PERSON
aji-132	276	3	7	CARDINAL
aji-132	276	4	1	CARDINAL
aji-132	277	1	79-89	DATE
aji-132	277	2	2024	DATE
aji-132	277	3	no.aji.115805	PERSON
aji-132	277	4	85 3	DATE
aji-132	279	1	a span of 24 weeks	DATE
aji-132	280	1	igu	ORG
aji-132	280	2	8 weeks	DATE
aji-132	282	1	igu	GPE
aji-132	282	2	25 mg	QUANTITY
aji-132	282	3	daily	DATE
aji-132	284	1	2012	DATE
aji-132	285	1	28	CARDINAL
aji-132	287	1	3-year	DATE
aji-132	292	1	ren et al	PERSON
aji-132	292	2	82	CARDINAL
aji-132	292	3	two	CARDINAL
aji-132	293	1	10 mg	QUANTITY
aji-132	293	2	weekly	DATE
aji-132	293	3	15 mg	CARDINAL
aji-132	293	4	weekly	DATE
aji-132	293	5	2 weeks	DATE
aji-132	294	1	igu	ORG
aji-132	294	2	25 mg	QUANTITY
aji-132	294	3	daily	DATE
aji-132	294	4	6 months	DATE
aji-132	295	1	90.24%	PERCENT
aji-132	295	2	78.05%	PERCENT
aji-132	295	3	41	CARDINAL
aji-132	298	1	66	CARDINAL
aji-132	298	2	two	CARDINAL
aji-132	299	1	10 mg	QUANTITY
aji-132	299	2	weekly	DATE
aji-132	299	3	25 mg	QUANTITY
aji-132	299	4	daily	DATE
aji-132	299	5	10 mg	CARDINAL
aji-132	299	6	weekly	DATE
aji-132	299	7	10 mg	QUANTITY
aji-132	299	8	daily	DATE
aji-132	299	9	16 weeks	DATE
aji-132	300	1	28	CARDINAL
aji-132	301	1	8 weeks	DATE
aji-132	301	2	two	CARDINAL
aji-132	301	3	american	NORP
aji-132	302	1	16 weeks	DATE
aji-132	302	2	two	CARDINAL
aji-132	303	1	igu	GPE
aji-132	304	1	igu	GPE
aji-132	307	1	up to 52 weeks	DATE
aji-132	308	1	131	CARDINAL
aji-132	308	2	three	CARDINAL
aji-132	309	1	1	CARDINAL
aji-132	309	2	44	CARDINAL
aji-132	309	3	twice daily	DATE
aji-132	310	1	2	CARDINAL
aji-132	310	2	38	CARDINAL
aji-132	310	3	25 mg	QUANTITY
aji-132	310	4	daily	DATE
aji-132	310	5	3	CARDINAL
aji-132	310	6	49	CARDINAL
aji-132	310	7	10 mg	DATE
aji-132	311	1	igu	CARDINAL
aji-132	311	2	between 4 and 10 weeks	CARDINAL
aji-132	312	1	igu with mtx	ORG
aji-132	312	2	igu gupta	GPE
aji-132	313	1	asian	NORP
aji-132	313	2	j. immunol	PERSON
aji-132	313	3	7	CARDINAL
aji-132	313	4	1	CARDINAL
aji-132	314	1	79-89	DATE
aji-132	314	2	2024	DATE
aji-132	314	3	no.aji.115805	PERSON
aji-132	314	4	86	CARDINAL
aji-132	315	1	igu	ORG
aji-132	317	1	igu	GPE
aji-132	318	1	wang et al	PERSON
aji-132	318	2	20	CARDINAL
aji-132	319	1	25 mg	QUANTITY
aji-132	319	2	daily	DATE
aji-132	319	3	8 mg	TIME
aji-132	319	4	daily	DATE
aji-132	320	1	7.5 mg	QUANTITY
aji-132	320	2	weekly	DATE
aji-132	321	1	igu	GPE
aji-132	321	2	25 mg	QUANTITY
aji-132	321	3	daily	DATE
aji-132	321	4	weekly	DATE
aji-132	321	5	12 weeks	DATE
aji-132	322	1	28	CARDINAL
aji-132	323	1	85% and 45%	PERCENT
aji-132	323	2	95%	PERCENT
aji-132	324	1	only one	CARDINAL
aji-132	325	1	igu, methylprednisolone	ORG
aji-132	326	1	igu	GPE
aji-132	327	1	4.	CARDINAL
aji-132	337	1	1	CARDINAL
aji-132	338	1	lee dm	PERSON
aji-132	340	1	lancet	ORG
aji-132	341	1	2001;358:903-11	CARDINAL
aji-132	342	1	2	CARDINAL
aji-132	342	2	american college of rheumatology subcommittee	ORG
aji-132	345	1	2002;46	CARDINAL
aji-132	345	2	328	CARDINAL
aji-132	346	1	aikawa y	PERSON
aji-132	346	2	yamamoto m	PERSON
aji-132	346	3	yamamoto t	PERSON
aji-132	346	4	morimoto k	PERSON
aji-132	346	5	tanaka k.	PERSON
aji-132	347	1	t-614	NORP
aji-132	349	1	4	CARDINAL
aji-132	350	1	tanaka k	PERSON
aji-132	350	2	yamamoto t	PERSON
aji-132	350	3	aikawa y	PERSON
aji-132	350	4	muramoto k	PERSON
aji-132	351	1	t-614	NORP
aji-132	351	2	asian	NORP
aji-132	351	3	j. immunol	PERSON
aji-132	351	4	7	CARDINAL
aji-132	351	5	1	CARDINAL
aji-132	352	1	79-89	DATE
aji-132	352	2	2024	DATE
aji-132	352	3	no.aji.115805 87	PERSON
aji-132	354	1	oxford	NORP
aji-132	355	1	2003;42(11):1365–1371	CARDINAL
aji-132	356	1	10.1093	CARDINAL
aji-132	356	2	5	CARDINAL
aji-132	357	1	kohno m	PERSON
aji-132	357	2	aikawa y	PERSON
aji-132	357	3	hashiramoto	PERSON
aji-132	357	4	kawahito y	PERSON
aji-132	357	5	t-614	NORP
aji-132	358	1	j. rheumatol	PERSON
aji-132	359	1	2001;28(12):2591	CARDINAL
aji-132	359	2	2596	DATE
aji-132	360	1	6	CARDINAL
aji-132	360	2	jiang y	PERSON
aji-132	360	3	lü w	PERSON
aji-132	360	4	yu s	PERSON
aji-132	360	5	xu g	PERSON
aji-132	361	1	xue xue bao	PERSON
aji-132	362	1	2006;41(5):401–405	CARDINAL
aji-132	362	2	gan k	PERSON
aji-132	362	3	yang l	PERSON
aji-132	362	4	xu l	GPE
aji-132	362	5	feng x	PERSON
aji-132	362	6	zhang q	PERSON
aji-132	362	7	wang f	PERSON
aji-132	362	8	t-614	NORP
aji-132	364	1	2016;35:294–300	CARDINAL
aji-132	364	2	doi:10.1016/j.intimp.2016.03.038 8	ORG
aji-132	365	1	tanaka k	PERSON
aji-132	365	2	makino s	PERSON
aji-132	365	3	aikawa y	PERSON
aji-132	365	4	inaba t	PERSON
aji-132	365	5	yoshida c.	PERSON
aji-132	366	1	1st	ORDINAL
aji-132	370	1	tanaka k	PERSON
aji-132	370	2	makino s	PERSON
aji-132	370	3	aikawa y	PERSON
aji-132	370	4	inaba t	PERSON
aji-132	370	5	yoshida c.	PERSON
aji-132	370	6	3formylamino-7-methylsulfonylamino-6phenoxy-4'-1-benzopyran-4-o	QUANTITY
aji-132	371	1	2nd	ORDINAL
aji-132	373	1	1992;42(7):945–50.google	CARDINAL
aji-132	373	2	10	CARDINAL
aji-132	374	1	tanaka k	PERSON
aji-132	374	2	makino s	PERSON
aji-132	374	3	asaoka k	ORG
aji-132	374	4	kitamura	GPE
aji-132	374	5	3formylamino-7	CARDINAL
aji-132	374	6	t-614	NORP
aji-132	375	1	3rd	ORDINAL
aji-132	376	1	j pharmacobio-dyn	PERSON
aji-132	378	1	10.1248	CARDINAL
aji-132	378	2	11	CARDINAL
aji-132	379	1	tanaka k	PERSON
aji-132	379	2	aikawa y	PERSON
aji-132	379	3	kawasaki h	ORG
aji-132	379	4	asaoka k	ORG
aji-132	379	5	inaba	GPE
aji-132	379	6	yoshida c.	PERSON
aji-132	379	7	3	CARDINAL
aji-132	379	8	t-614	NORP
aji-132	380	1	4th	ORDINAL
aji-132	380	2	interleukin6	WORK_OF_ART
aji-132	381	1	j pharmacobio-dyn	PERSON
aji-132	382	1	1992;15(11):649	ORDINAL
aji-132	382	2	55	DATE
aji-132	383	1	10.1248/	MONEY
aji-132	383	2	12	CARDINAL
aji-132	384	1	tanaka k	PERSON
aji-132	384	2	kawasaki h	GPE
aji-132	384	3	kurata k	PERSON
aji-132	384	4	aikawa y	PERSON
aji-132	384	5	inaba t. t-614	PERSON
aji-132	385	1	jpn j pharmacol	PERSON
aji-132	386	1	1995;67(4):305–14	CARDINAL
aji-132	386	2	10.1254	CARDINAL
aji-132	386	3	13	CARDINAL
aji-132	387	1	tanaka k	PERSON
aji-132	387	2	yamamoto t	PERSON
aji-132	387	3	aikawa y	PERSON
aji-132	387	4	muramoto k	PERSON
aji-132	388	1	t-614	NORP
aji-132	389	1	oxford	NORP
aji-132	390	1	2003;42(11):1365–71	CARDINAL
aji-132	391	1	10.1093	CARDINAL
aji-132	391	2	keg381 14	ORG
aji-132	392	1	morimoto k	PERSON
aji-132	392	2	tanaka k. antiallodynic	PERSON
aji-132	394	1	2017;66(10):855–62	CARDINAL
aji-132	395	1	10.1007	CARDINAL
aji-132	396	1	jiang xp	PERSON
aji-132	396	2	huang xl	PERSON
aji-132	396	3	yang zp	PERSON
aji-132	396	4	wang sc	PERSON
aji-132	396	5	xie w	PERSON
aji-132	396	6	miao l	ORG
aji-132	396	7	th17/treg	ORG
aji-132	398	1	2018;93:9–19	CARDINAL
aji-132	399	1	doi:10.1016	GPE
aji-132	399	2	16	CARDINAL
aji-132	400	1	li g	PERSON
aji-132	400	2	yamasaki r	PERSON
aji-132	400	3	masaki k	PERSON
aji-132	400	4	ochi h	ORG
aji-132	400	5	matsushita	ORG
aji-132	401	1	sci rep	ORG
aji-132	401	2	2018;8(1):1933	TIME
aji-132	401	3	10.1038	CARDINAL
aji-132	402	1	kohno m	PERSON
aji-132	402	2	aikawa y	PERSON
aji-132	402	3	hashiramoto	PERSON
aji-132	402	4	kawahito y	PERSON
aji-132	402	5	t-614	NORP
aji-132	405	1	18	CARDINAL
aji-132	406	1	aikawa y	PERSON
aji-132	406	2	yamamoto m	PERSON
aji-132	406	3	yamamoto t	PERSON
aji-132	406	4	morimoto k	PERSON
aji-132	406	5	tanaka k.	PERSON
aji-132	407	1	t-614	NORP
aji-132	409	1	2002;51	CARDINAL
aji-132	409	2	4): 188–94	DATE
aji-132	409	3	asian	NORP
aji-132	409	4	j. immunol	PERSON
aji-132	410	1	7	CARDINAL
aji-132	410	2	1	CARDINAL
aji-132	411	1	79-89	DATE
aji-132	411	2	2024	DATE
aji-132	411	3	no.aji.115805	PERSON
aji-132	411	4	88 19	DATE
aji-132	412	1	jiang h	PERSON
aji-132	412	2	gao h	ORG
aji-132	412	3	wang	PERSON
aji-132	412	4	wang m	PERSON
aji-132	412	5	wu b.	PERSON
aji-132	412	6	biomed pharmacother	PERSON
aji-132	413	1	109704	DATE
aji-132	414	1	doi:10.1016/j.biopha.2019.109704	ORG
aji-132	414	2	20	CARDINAL
aji-132	415	1	li	PERSON
aji-132	415	2	li p	PERSON
aji-132	415	3	bi l.	PERSON
aji-132	415	4	2	CARDINAL
aji-132	415	5	4	CARDINAL
aji-132	416	1	clin	PERSON
aji-132	417	1	2020;39(3):899–907	CARDINAL
aji-132	417	2	yan	PERSON
aji-132	418	1	huang x	PERSON
aji-132	418	2	fu q	PERSON
aji-132	418	3	chen s	PERSON
aji-132	418	4	dai	ORG
aji-132	418	5	mrl	PERSON
aji-132	419	1	plos one	PERSON
aji-132	420	1	2014;9(10):e108273	CARDINAL
aji-132	422	1	liu m	PERSON
aji-132	422	2	liu y	PERSON
aji-132	422	3	hao p	PERSON
aji-132	423	1	pkc/egr1	ORG
aji-132	426	1	2019;21(1):92	TIME
aji-132	426	2	2 23	CARDINAL
aji-132	427	1	tanaka k	PERSON
aji-132	427	2	yamamoto t	PERSON
aji-132	427	3	taniguchi y	PERSON
aji-132	427	4	muramoto k.	PERSON
aji-132	427	5	t-614	NORP
aji-132	429	1	2004;50	CARDINAL
aji-132	430	1	24	CARDINAL
aji-132	431	1	yamamoto t	PERSON
aji-132	431	2	aikawa y	PERSON
aji-132	431	3	t-614	NORP
aji-132	433	1	2007	DATE
aji-132	433	2	35:561-9	DATE
aji-132	435	1	muramoto k	PERSON
aji-132	435	2	yamamoto t	PERSON
aji-132	435	3	tanaka k.	PERSON
aji-132	436	1	t-614	NORP
aji-132	437	1	2004	DATE
aji-132	437	2	quebec	GPE
aji-132	437	3	canada	GPE
aji-132	438	1	26	CARDINAL
aji-132	439	1	tanaka k	PERSON
aji-132	439	2	taniguchi y	PERSON
aji-132	439	3	t-614	NORP
aji-132	439	4	dba/1j	ORG
aji-132	439	5	mrl/l	ORG
aji-132	441	1	1993;9:69-78	DATE
aji-132	442	1	27	CARDINAL
aji-132	443	1	yamamoto m	PERSON
aji-132	443	2	taniguchi y	PERSON
aji-132	443	3	t-614	NORP
aji-132	445	1	2007;35:571	CARDINAL
aji-132	446	1	28	CARDINAL
aji-132	446	2	de vita s	PERSON
aji-132	446	3	zaja f	PERSON
aji-132	446	4	sacco s	PERSON
aji-132	449	1	2002;46	CARDINAL
aji-132	449	2	2029-33	ORG
aji-132	450	1	29	CARDINAL
aji-132	451	1	yamamoto m	PERSON
aji-132	451	2	yamamoto t	PERSON
aji-132	451	3	t-614	NORP
aji-132	453	1	2007;35:551-9	CARDINAL
aji-132	454	1	jiang y	PERSON
aji-132	454	2	lü w	PERSON
aji-132	454	3	yu sq	PERSON
aji-132	455	1	xue xue bao	PERSON
aji-132	456	1	2006;41:401	CARDINAL
aji-132	457	1	kohno m	PERSON
aji-132	457	2	aikawa y	PERSON
aji-132	457	3	t-614	NORP
aji-132	459	1	2001;28:2591-6	CARDINAL
aji-132	460	1	kawakami	PERSON
aji-132	460	2	urayama s	PERSON
aji-132	460	3	t-614	NORP
aji-132	462	1	1999;133:566-74	CARDINAL
aji-132	463	1	33	CARDINAL
aji-132	464	1	aikawa y	PERSON
aji-132	465	1	t-614	NORP
aji-132	466	1	j neuroimmunol	PERSON
aji-132	467	1	1998;89:35-42	CARDINAL
aji-132	468	1	34	CARDINAL
aji-132	469	1	tanaka k	PERSON
aji-132	469	2	mikami m	PERSON
aji-132	469	3	26	CARDINAL
aji-132	471	1	2007;56:17	CARDINAL
aji-132	473	1	du f	PERSON
aji-132	473	2	lü lj	PERSON
aji-132	473	3	fu	PERSON
aji-132	474	1	t-614	NORP
aji-132	476	1	2008;10	PERSON
aji-132	477	1	36	CARDINAL
aji-132	477	2	ruiz s	PERSON
aji-132	478	1	dlx5	ORG
aji-132	478	2	j. biol	PERSON
aji-132	480	1	2008;283(7):3816	CARDINAL
aji-132	480	2	3826	CARDINAL
aji-132	481	1	37	CARDINAL
aji-132	482	1	song j	PERSON
aji-132	482	2	t-614	NORP
aji-132	484	1	4901591	DATE
aji-132	485	1	38	DATE
aji-132	486	1	yamaguchi m	PERSON
aji-132	486	2	weitzmann mn	GPE
aji-132	487	1	honokiol	ORG
aji-132	488	1	j. mol	PERSON
aji-132	490	1	39	CARDINAL
aji-132	491	1	lacey dl	PERSON
aji-132	491	2	timms e	PERSON
aji-132	491	3	tan hl	PERSON
aji-132	492	1	asian	NORP
aji-132	492	2	j. immunol	PERSON
aji-132	492	3	7	CARDINAL
aji-132	492	4	1	CARDINAL
aji-132	493	1	79-89	DATE
aji-132	493	2	2024	DATE
aji-132	493	3	no.aji.115805 89	PERSON
aji-132	494	1	1998;93(2):165–176	CARDINAL
aji-132	496	1	wang xt	PERSON
aji-132	496	2	li p	PERSON
aji-132	496	3	xu ts	PERSON
aji-132	496	4	zhang x	PERSON
aji-132	496	5	bi lq	PERSON
aji-132	501	1	41	CARDINAL
aji-132	502	1	ren yh	PERSON
aji-132	502	2	dong w	PERSON
aji-132	502	3	liu h	PERSON
aji-132	502	4	liu l.	PERSON
aji-132	502	5	china	GPE
aji-132	503	1	2017;28(32):4530–4532	CARDINAL
aji-132	504	1	42	DATE
aji-132	505	1	wu yx	PERSON
aji-132	505	2	sun y	PERSON
aji-132	509	1	gan k	PERSON
aji-132	509	2	yang l	PERSON
aji-132	512	1	immunopharmacol	GPE
aji-132	512	2	2016	CARDINAL
aji-132	513	1	35:294–300	CARDINAL
aji-132	515	1	du f	PERSON
aji-132	515	2	lu lj	PERSON
aji-132	515	3	teng	PERSON
aji-132	515	4	t-614	NORP
aji-132	516	1	immunopharmacol	GPE
aji-132	517	1	2012;13(1):54	CARDINAL
aji-132	517	2	60	CARDINAL
aji-132	518	1	45	CARDINAL
aji-132	519	1	winthrop kl	ORG
aji-132	522	1	2010;69(6):976–986	CARDINAL
aji-132	523	1	46	DATE
aji-132	524	1	wei y	PERSON
aji-132	524	2	sun x	PERSON
aji-132	524	3	hua m	PERSON
aji-132	524	4	tan w	PERSON
aji-132	524	5	wang f	PERSON
aji-132	524	6	zhang m	PERSON
aji-132	524	7	t-614	NORP
aji-132	608	1	2024	DATE